BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37432458)

  • 1. Development and external validation of a prediction model for brain metastases in patients with metastatic breast cancer.
    Wu Q; Sun MS; Liu YH; Ye JM; Xu L
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12333-12353. PubMed ID: 37432458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation of a published nomogram for prediction of brain metastasis in patients with extra-cerebral metastatic breast cancer and risk regression analysis.
    Genre L; Roché H; Varela L; Kanoun D; Ouali M; Filleron T; Dalenc F
    Eur J Cancer; 2017 Feb; 72():200-209. PubMed ID: 28042991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple-negative breast cancer.
    Lin M; Jin Y; Jin J; Wang B; Hu X; Zhang J
    Cancer Med; 2020 Nov; 9(22):8540-8551. PubMed ID: 32945619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study.
    Zhang M; Wang B; Liu N; Wang H; Zhang J; Wu L; Zhao A; Wang L; Zhao X; Yang J
    BMC Cancer; 2021 May; 21(1):565. PubMed ID: 34001061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.
    Darlix A; Hirtz C; Thezenas S; Maceski A; Gabelle A; Lopez-Crapez E; De Forges H; Firmin N; Guiu S; Jacot W; Lehmann S
    BMC Cancer; 2019 Jan; 19(1):110. PubMed ID: 30700265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A visualized model for identifying optimal candidates for aggressive locoregional surgical treatment in patients with bone metastases from breast cancer.
    Tong Y; Xu S; Jiang L; Zhao C; Zhao D
    Front Endocrinol (Lausanne); 2023; 14():1266679. PubMed ID: 37867528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of death probability in adenocarcinoma of the transverse colon: competing-risk nomograms based on 21,469 patients.
    Su H; Wang S; Xie S; Huang L; Pan Y; Lyu J
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10435-10452. PubMed ID: 37278827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia.
    Degnim AC; Winham SJ; Frank RD; Pankratz VS; Dupont WD; Vierkant RA; Frost MH; Hoskin TL; Vachon CM; Ghosh K; Hieken TJ; Carter JM; Denison LA; Broderick B; Hartmann LC; Visscher DW; Radisky DC
    J Clin Oncol; 2018 Jun; 36(18):1840-1846. PubMed ID: 29676945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.
    Tseng TE; Lee CC; Yen HK; Groot OQ; Hou CH; Lin SY; Bongers MER; Hu MH; Karhade AV; Ko JC; Lai YH; Yang JJ; Verlaan JJ; Yang RS; Schwab JH; Lin WH
    Clin Orthop Relat Res; 2022 Feb; 480(2):367-378. PubMed ID: 34491920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery.
    Lin C; Wu J; Ding S; Goh C; Andriani L; Lu S; Shen K; Zhu L
    J Natl Compr Canc Netw; 2019 Dec; 17(12):1521-1528. PubMed ID: 31805535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study.
    Li Z; Shi Y; Wu L; Zhang H; Xue J; Li W; Wang X; Zhang L; Wang Q; Duo L; Wang M; Wang G
    Gland Surg; 2022 Dec; 11(12):1961-1975. PubMed ID: 36654948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China.
    Li Y; Li Q; Mo H; Guan X; Lin S; Wang Z; Chen Y; Zhang Y; Zhang D; Chen S; Cai R; Wang J; Luo Y; Fan Y; Yuan P; Zhang P; Li Q; Ma F; Xu B
    Breast; 2021 Feb; 55():30-36. PubMed ID: 33310633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
    Sun M; De Velasco G; Brastianos PK; Aizer AA; Martin A; Moreira R; Nguyen PL; Trinh QD; Choueiri TK
    Eur Urol Focus; 2019 May; 5(3):474-481. PubMed ID: 29311016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and validation of a nomogram for progression to diabetic foot ulcers in elderly diabetic patients.
    Shao Z; Wang Z; Bi S; Zhang J
    Front Endocrinol (Lausanne); 2023; 14():1107830. PubMed ID: 37082126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
    Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
    Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors.
    Berghoff AS; Bago-Horvath Z; Ilhan-Mutlu A; Magerle M; Dieckmann K; Marosi C; Birner P; Widhalm G; Steger GG; Zielinski CC; Bartsch R; Preusser M
    Br J Cancer; 2012 Oct; 107(9):1454-8. PubMed ID: 23047551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
    Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
    BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a prognostic risk prediction modelfor non-small cell lung cancer patients with brainmetastases: a retrospective study.
    Hou F; Hou Y; Sun XD; Lv J; Jiang HM; Zhang M; Liu C; Deng ZY
    PeerJ; 2023; 11():e15678. PubMed ID: 37456882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Prognostic App (iCanPredict) to Predict Survival for Chinese Women With Breast Cancer: Retrospective Study.
    Ma Z; Huang S; Wu X; Huang Y; Chan SW; Lin Y; Zheng X; Zhu J
    J Med Internet Res; 2022 Mar; 24(3):e35768. PubMed ID: 35262503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nomogram for predicting the risk of male breast cancer for overall survival.
    Wen Y; Bai J; Zheng C; Liu J; Lin S; Han H; Xu C
    Front Oncol; 2023; 13():1068187. PubMed ID: 37601680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.